Find the Perfect Plan for Your Investment Journey
G
Last Price
52 Week Range
CA$6.66 - CA$21.50
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Last Price
Market Cap | CA$1.93B |
EV | CA$2.45B |
Shares Outstanding | 236.99M |
Beta | 1.46 |
Analyst Rating | BUY |
Analyst Target Price | CA$14.11 |
P/E 2025E | 27.50x |
P/Revenue 2025E | 1.18x |
Revenue | 8.40% |
EPS | -3.10% |
Operating Cash Flow | 13.90% |
Free Cash Flow | - |
Revenue | 4.90% |
EPS | 27.40% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 51.50% |
Net Profit Margin 2025E | 4.05% |
ROE 2025E | 6.00% |
ROCE 2024 | 4.19% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Green Thumb Industries Inc.
GTII
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kovler, Benjamin
Employees
4,800
Website
www.gtigrows.comIPO Date
2003-10-28
Headquarters
325 West Huron Street, Suite 700, Chicago, Illinois, 60654, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved